Cargando…
Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial
Background: Type 2 diabetes mellitus and obesity are both related to endothelial dysfunction. Postprandial lipemia is a cardiovascular risk. Notably, it is known that a high-fat diet may elicit microvascular dysfunction, even in healthy subjects. Since anti-diabetic drugs have different mechanisms o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601890/ https://www.ncbi.nlm.nih.gov/pubmed/33050169 http://dx.doi.org/10.3390/jcm9103228 |
_version_ | 1783603540197900288 |
---|---|
author | Schiappacassa, Alessandra Maranhão, Priscila A. de Souza, Maria das Graças Coelho Panazzolo, Diogo G. Nogueira Neto, José Firmino Bouskela, Eliete Kraemer-Aguiar, Luiz Guilherme |
author_facet | Schiappacassa, Alessandra Maranhão, Priscila A. de Souza, Maria das Graças Coelho Panazzolo, Diogo G. Nogueira Neto, José Firmino Bouskela, Eliete Kraemer-Aguiar, Luiz Guilherme |
author_sort | Schiappacassa, Alessandra |
collection | PubMed |
description | Background: Type 2 diabetes mellitus and obesity are both related to endothelial dysfunction. Postprandial lipemia is a cardiovascular risk. Notably, it is known that a high-fat diet may elicit microvascular dysfunction, even in healthy subjects. Since anti-diabetic drugs have different mechanisms of action and also distinct vascular benefits, we aimed to compare the results of two anti-diabetic drugs after the intake of a lipid-rich meal on microcirculation in patients with type 2 diabetes and obesity. In parallel, we also investigated the metabolic profile, oxidative stress, inflammation, plasma viscosity, and some gastrointestinal peptides. Subjects/Methods: We included 38 drug-naïve patients, all women aged between 19 and 50 years, with BMI ≥ 30 kg/m(2). We performed endothelial measurements and collected samples before (fasting) and after the intake of a lipid-rich meal at 30, 60, 120, and 180 min. Patients were randomized to metformin or vildagliptin, given orally just before the meal. Endothelial function was assessed by videocapillaroscopy and laser-Doppler flowmetry to investigate microvascular reactivity. Besides, we also investigated plasma viscosity, inflammatory and oxidative stress biomarkers, gastrointestinal peptides, and metabolic profile in all time points. Results: No differences at baseline were noted between groups. Vildagliptin increased glucagon-like peptide-1 compared to metformin. Paired comparisons showed that, during the postprandial period, vildagliptin significantly changed levels of insulin and glucagon-like peptide-1, and also the dipeptidyl peptidase-4 activity, while metformin had effects on plasma glucose solely. Metformin use during the test meal promoted an increase in functional capillary density, while vildagliptin kept non-nutritive microvascular blood flow and vasomotion unchanged. Conclusions: After the intake of a lipid-rich meal, the use of vildagliptin preserved postprandial non-nutritive microflow and vasomotion, while metformin increased capillary recruitment, suggesting protective and different mechanisms of action on microcirculation. |
format | Online Article Text |
id | pubmed-7601890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76018902020-11-01 Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial Schiappacassa, Alessandra Maranhão, Priscila A. de Souza, Maria das Graças Coelho Panazzolo, Diogo G. Nogueira Neto, José Firmino Bouskela, Eliete Kraemer-Aguiar, Luiz Guilherme J Clin Med Article Background: Type 2 diabetes mellitus and obesity are both related to endothelial dysfunction. Postprandial lipemia is a cardiovascular risk. Notably, it is known that a high-fat diet may elicit microvascular dysfunction, even in healthy subjects. Since anti-diabetic drugs have different mechanisms of action and also distinct vascular benefits, we aimed to compare the results of two anti-diabetic drugs after the intake of a lipid-rich meal on microcirculation in patients with type 2 diabetes and obesity. In parallel, we also investigated the metabolic profile, oxidative stress, inflammation, plasma viscosity, and some gastrointestinal peptides. Subjects/Methods: We included 38 drug-naïve patients, all women aged between 19 and 50 years, with BMI ≥ 30 kg/m(2). We performed endothelial measurements and collected samples before (fasting) and after the intake of a lipid-rich meal at 30, 60, 120, and 180 min. Patients were randomized to metformin or vildagliptin, given orally just before the meal. Endothelial function was assessed by videocapillaroscopy and laser-Doppler flowmetry to investigate microvascular reactivity. Besides, we also investigated plasma viscosity, inflammatory and oxidative stress biomarkers, gastrointestinal peptides, and metabolic profile in all time points. Results: No differences at baseline were noted between groups. Vildagliptin increased glucagon-like peptide-1 compared to metformin. Paired comparisons showed that, during the postprandial period, vildagliptin significantly changed levels of insulin and glucagon-like peptide-1, and also the dipeptidyl peptidase-4 activity, while metformin had effects on plasma glucose solely. Metformin use during the test meal promoted an increase in functional capillary density, while vildagliptin kept non-nutritive microvascular blood flow and vasomotion unchanged. Conclusions: After the intake of a lipid-rich meal, the use of vildagliptin preserved postprandial non-nutritive microflow and vasomotion, while metformin increased capillary recruitment, suggesting protective and different mechanisms of action on microcirculation. MDPI 2020-10-09 /pmc/articles/PMC7601890/ /pubmed/33050169 http://dx.doi.org/10.3390/jcm9103228 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schiappacassa, Alessandra Maranhão, Priscila A. de Souza, Maria das Graças Coelho Panazzolo, Diogo G. Nogueira Neto, José Firmino Bouskela, Eliete Kraemer-Aguiar, Luiz Guilherme Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title | Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title_full | Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title_fullStr | Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title_full_unstemmed | Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title_short | Acute Effects of Metformin and Vildagliptin after a Lipid-Rich Meal on Postprandial Microvascular Reactivity in Patients with Type 2 Diabetes and Obesity: A Randomized Trial |
title_sort | acute effects of metformin and vildagliptin after a lipid-rich meal on postprandial microvascular reactivity in patients with type 2 diabetes and obesity: a randomized trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601890/ https://www.ncbi.nlm.nih.gov/pubmed/33050169 http://dx.doi.org/10.3390/jcm9103228 |
work_keys_str_mv | AT schiappacassaalessandra acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT maranhaopriscilaa acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT desouzamariadasgracascoelho acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT panazzolodiogog acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT nogueiranetojosefirmino acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT bouskelaeliete acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial AT kraemeraguiarluizguilherme acuteeffectsofmetforminandvildagliptinafteralipidrichmealonpostprandialmicrovascularreactivityinpatientswithtype2diabetesandobesityarandomizedtrial |